ULTRASE

Welcome to the Brand page for “ULTRASE”, which is offered here for In the statement, column 1, before line 1, scandipharm, inc. (delaware corporation) 22 iverness center parkway, birmingham, al 35242, by merger with should be inserted.;pancreatic enzyme, pancrelipase, for the treatment of pancreatic enzyme deficiency;.

Its status is currently believed to be active. Its class is unavailable. “ULTRASE” is believed to be currently owned by “APTALIS PHARMA US, INC.”


Owner:
APTALIS PHARMA US, INC.
Owner Details
Description:
IN THE STATEMENT, COLUMN 1, BEFORE LINE 1, SCANDIPHARM, INC. (DELAWARE CORPORATION) 22 IVERNESS CENTER PARKWAY, BIRMINGHAM, AL 35242, BY MERGER WITH SHOULD BE INSERTED.;pancreatic enzyme, pancrelipase, for the treatment of pancreatic enzyme deficiency;
Categories: STATEMENT